Construction and Characterization of a Novel Fusion Protein MG7-scFv/SEB against Gastric Cancer
Figure 5
DNA ladder after treating with MG7-scFv/SEB. Lane 1: 10 g/mL MG7-scFv/SEB group; lane 2: 1.0 g/mL MG7-scFv/SEB group; lane 3: 0.1 g/mL MG7-scFv/SEB group; lane 4: normal sodium group.